[HTML][HTML] Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the …
X Sun, B Shi, H Zheng, L Min, J Yang, X Li, X Liao… - Cell Death & …, 2018 - nature.com
Although targeted therapy and immunotherapy greatly improve the outcome of melanoma,
drug resistance and low response rates still maintain the unsubstitutability of traditional …
drug resistance and low response rates still maintain the unsubstitutability of traditional …
Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2 …
X Sun, B Shi, H Zheng, M Ling, J Yang… - Cell Death and …, 2018 - search.proquest.com
Although targeted therapy and immunotherapy greatly improve the outcome of melanoma,
drug resistance and low response rates still maintain the unsubstitutability of traditional …
drug resistance and low response rates still maintain the unsubstitutability of traditional …
[HTML][HTML] Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the …
X Sun, B Shi, H Zheng, L Min, J Yang, X Li… - Cell Death & …, 2018 - ncbi.nlm.nih.gov
Although targeted therapy and immunotherapy greatly improve the outcome of melanoma,
drug resistance and low response rates still maintain the unsubstitutability of traditional …
drug resistance and low response rates still maintain the unsubstitutability of traditional …
Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2 …
X Sun, B Shi, H Zheng, L Min, J Yang… - Cell death & …, 2018 - pubmed.ncbi.nlm.nih.gov
Although targeted therapy and immunotherapy greatly improve the outcome of melanoma,
drug resistance and low response rates still maintain the unsubstitutability of traditional …
drug resistance and low response rates still maintain the unsubstitutability of traditional …
Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2 …
X Sun, B Shi, H Zheng, L Min, J Yang, X Li… - Cell Death & …, 2018 - search.ebscohost.com
Although targeted therapy and immunotherapy greatly improve the outcome of melanoma,
drug resistance and low response rates still maintain the unsubstitutability of traditional …
drug resistance and low response rates still maintain the unsubstitutability of traditional …
Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2 …
X Sun, B Shi, H Zheng, L Min, J Yang, X Li, X Liao… - Cell Death & …, 2018 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Although targeted therapy and immunotherapy
greatly improve the outcome of melanoma, drug resistance and low response rates still …
greatly improve the outcome of melanoma, drug resistance and low response rates still …
Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2 …
X Sun, B Shi, H Zheng, L Min, J Yang, X Li… - Cell Death & …, 2018 - europepmc.org
Although targeted therapy and immunotherapy greatly improve the outcome of melanoma,
drug resistance and low response rates still maintain the unsubstitutability of traditional …
drug resistance and low response rates still maintain the unsubstitutability of traditional …